arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Friday 2 July 2021

Friday 02 Jul

SESSION 5: HOW TO COMBINE IMMUNOTHERAPY WITH STANDARD OF CARE

08:30

Keynote lecture: Checkpoint inhibition in the radical setting for H&N SCC

09:00

neo-adjuvant immunotherapy in HNSCC

Charlotte Zuur

09:15

Radiation with immunotherapy

Kevin Harrington, United Kingdom

09:30

Therapeutic vaccines in HPV+ disease

Christophe Le Tourneau, France

09:45

Proferred papers related to session 5

Moderator: Vincent Grégoire, Belgium

10:15

Coffee Break

SESSION 6: HOW WILL WE TREAT OUR PATIENTS NON-SURGICALLY IN 2030?

Chair: Jesper Grau-Eriksen & Jean-Pascal Machiels

10:45

Modern day adaptive RT.

11:05

Treatment adaptation for HPV positive disease.

Pernille Lassen, Denmark

11:25

Systemic therapy: immune checkpoint inhibitors, still cisplatin, …

Sylvie Rottey, Belgium

11:45

Proferred papers related to session 6

Chair: Igor Reshetov

12:30

Lunch / virtual booth visit

12:45

Satellite Symposium

SESSION 7: QUALITY OF CARE IN TREATMENT OF HEAD AND NECK CANCER AND SURVIVORSHIP

Chair: Andreas Dietz, Germany & Moderator: G. Succo, Italy

14:00

How to improve Quality of Care in Surgical Oncology.

René Leemans, The Netherlands

14:20

What really matters is the radiation oncologist behind the machine

Vincent Grégoire, Belgium

14:40

Optimizing the prescription doses and tolerability of systemic therapy

Thorsten Fureder, Austria

15:00

Health related quality of life from diagnosis up to 2 years after treatment: evidence from NET-QUBIC

Irma Verdonck-de Leeuw, The Netherlands

15:20

Value based health care.

Yolande Lievens, Belgium

15:40

Proferred papers related to session 7

16:00

Coffee Break

SESSION 8: THYROID CANCER

16:30

Surveillance vs. treatment of papillary thyroid cancer

16:50

New treatment options in iodine-refractory thyroid cancer

Laura Locati, Italy

17:10

Proferred papers related to session 8

Moderator: Ricard Simo

17:55

Concluding remarks